At least seven biotech and pharmas are slated to report earnings this week. Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) is expected to report quarterly EPS growth of 29%. The company, which markets hemolytic anemia drug Soliris eculizumab, is expected to report top-line growth of